AKO.A vs. CELH, FIZZ, ZVIA, REED, KOF, MNST, CCEP, FMX, PRMB, and COKE
Should you be buying Embotelladora Andina SA ADR Series A stock or one of its competitors? The main competitors of Embotelladora Andina SA ADR Series A include Celsius (CELH), National Beverage (FIZZ), Zevia PBC (ZVIA), Reed's (REED), Coca-Cola FEMSA (KOF), Monster Beverage (MNST), Coca-Cola Europacific Partners (CCEP), Fomento Económico Mexicano (FMX), Primo Brands (PRMB), and Coca-Cola Consolidated (COKE). These companies are all part of the "bottled & canned soft drinks" industry.
Embotelladora Andina SA ADR Series A vs.
Embotelladora Andina SA ADR Series A (NYSE:AKO.A) and Celsius (NASDAQ:CELH) are both mid-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, community ranking, valuation, media sentiment, earnings and analyst recommendations.
Embotelladora Andina SA ADR Series A has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500. Comparatively, Celsius has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500.
Celsius received 204 more outperform votes than Embotelladora Andina SA ADR Series A when rated by MarketBeat users. Likewise, 64.20% of users gave Celsius an outperform vote while only 59.34% of users gave Embotelladora Andina SA ADR Series A an outperform vote.
In the previous week, Celsius had 16 more articles in the media than Embotelladora Andina SA ADR Series A. MarketBeat recorded 17 mentions for Celsius and 1 mentions for Embotelladora Andina SA ADR Series A. Celsius' average media sentiment score of 0.07 beat Embotelladora Andina SA ADR Series A's score of 0.00 indicating that Celsius is being referred to more favorably in the news media.
Celsius has a consensus target price of $48.00, suggesting a potential upside of 86.19%. Given Celsius' stronger consensus rating and higher possible upside, analysts clearly believe Celsius is more favorable than Embotelladora Andina SA ADR Series A.
0.1% of Embotelladora Andina SA ADR Series A shares are held by institutional investors. Comparatively, 61.0% of Celsius shares are held by institutional investors. 0.0% of Embotelladora Andina SA ADR Series A shares are held by insiders. Comparatively, 2.2% of Celsius shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Celsius has a net margin of 15.61% compared to Embotelladora Andina SA ADR Series A's net margin of 7.37%. Celsius' return on equity of 59.40% beat Embotelladora Andina SA ADR Series A's return on equity.
Celsius has lower revenue, but higher earnings than Embotelladora Andina SA ADR Series A. Embotelladora Andina SA ADR Series A is trading at a lower price-to-earnings ratio than Celsius, indicating that it is currently the more affordable of the two stocks.
Summary
Celsius beats Embotelladora Andina SA ADR Series A on 16 of the 18 factors compared between the two stocks.
Get Embotelladora Andina SA ADR Series A News Delivered to You Automatically
Sign up to receive the latest news and ratings for AKO.A and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AKO.A vs. The Competition
Embotelladora Andina SA ADR Series A Competitors List
Related Companies and Tools
This page (NYSE:AKO.A) was last updated on 1/30/2025 by MarketBeat.com Staff
